ATE195949T1 - Verfahren und zusammensetzungen zur behandlung der thrombose - Google Patents

Verfahren und zusammensetzungen zur behandlung der thrombose

Info

Publication number
ATE195949T1
ATE195949T1 AT94920270T AT94920270T ATE195949T1 AT E195949 T1 ATE195949 T1 AT E195949T1 AT 94920270 T AT94920270 T AT 94920270T AT 94920270 T AT94920270 T AT 94920270T AT E195949 T1 ATE195949 T1 AT E195949T1
Authority
AT
Austria
Prior art keywords
peptides
amino acid
contain
hydrophobic amino
compositions
Prior art date
Application number
AT94920270T
Other languages
English (en)
Inventor
Michael D Pierschbacher
Soan Cheng
William S Craig
Juerg F Tschopp
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Application granted granted Critical
Publication of ATE195949T1 publication Critical patent/ATE195949T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94920270T 1993-06-18 1994-06-17 Verfahren und zusammensetzungen zur behandlung der thrombose ATE195949T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7944193A 1993-06-18 1993-06-18
US17106893A 1993-12-20 1993-12-20
PCT/US1994/006913 WO1995000544A1 (en) 1993-06-18 1994-06-17 Method and composition for treating thrombosis

Publications (1)

Publication Number Publication Date
ATE195949T1 true ATE195949T1 (de) 2000-09-15

Family

ID=26762011

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920270T ATE195949T1 (de) 1993-06-18 1994-06-17 Verfahren und zusammensetzungen zur behandlung der thrombose

Country Status (7)

Country Link
EP (1) EP0705274B1 (de)
JP (1) JPH09501910A (de)
AT (1) ATE195949T1 (de)
AU (1) AU7112794A (de)
CA (1) CA2165332A1 (de)
DE (1) DE69425745T2 (de)
WO (1) WO1995000544A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
EP0727225A3 (de) * 1995-02-14 1997-01-15 Sonus Pharma Inc Zusammensetzungen und Verfahren zur Herstellung von gerichteter Ultraschallabbildung
US5858972A (en) * 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
US6235877B1 (en) 1999-08-04 2001-05-22 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7790362B2 (en) 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
US7595169B2 (en) * 2005-04-27 2009-09-29 Accumetrics, Inc. Method for determining percent platelet aggregation
CA2623565A1 (en) 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
WO2007113386A1 (en) * 2006-03-31 2007-10-11 Karyon-Ctt Ltd Peptide conjugates
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
CN119529115B (zh) * 2024-12-11 2025-11-11 浙江大学 靶向内皮的肽及在预防和治疗糖尿病下肢缺血中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
DK0527798T3 (da) * 1990-04-06 1997-12-15 Jolla Cancer Res Found Fremgangsmåde og sammensætning til behandling af thrombose
US5192746A (en) * 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds

Also Published As

Publication number Publication date
WO1995000544A1 (en) 1995-01-05
DE69425745D1 (de) 2000-10-05
EP0705274A1 (de) 1996-04-10
DE69425745T2 (de) 2001-04-19
JPH09501910A (ja) 1997-02-25
EP0705274B1 (de) 2000-08-30
CA2165332A1 (en) 1995-01-05
AU7112794A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
DE69126871D1 (de) Verfahren und verbindung zur behandlung von thrombose
DE69011102T2 (de) Hydrophobe bindungsstelle für adhäsionspeptide.
ATE195949T1 (de) Verfahren und zusammensetzungen zur behandlung der thrombose
Lee et al. Osteoblastic differentiation of human bone marrow stromal cells in self-assembled BMP-2 receptor-binding peptide-amphiphiles
DK0661989T3 (da) Proteinsammensætninger med vedvarende frigivelse
DE69713112D1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
IL109403A0 (en) Oral drug delivery compositions and methods
IL128829A0 (en) Improved solid-phase peptide and agent for use in such synthesis
DK0831773T3 (da) Suspenderede peptid/proteinformuleringer
ATE137245T1 (de) Synthetische peptide zum in vivo nachweis von thrombosen
Krstenansky et al. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin
TW364850B (en) Nematocidal compositions
Otto et al. Dipeptide uptake by adenohypophysial folliculostellate cells
GB2630898A8 (en) Methods and compositions for delivery of biotin to mitochondria
DE59712235D1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
US20040220110A1 (en) Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
HU0102043D0 (en) Pharmaceutical compounds which interact with an ca2+ channel alpha2delta subunit
Enomoto et al. Demonstration of receptors for parathyroid hormone on cultured rabbit costal chondrocytes
EP1548029A2 (de) Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften III
CA2453202A1 (en) Peptides which modulate blood coagulation and methods of use thereof
Gerdin et al. Structural requirements for microvascular permeability-increasing ability of peptides: Studies on analogues of a fibrinogen pentapeptide fragment
ATE427955T1 (de) Zusammensetzungen und verfahren zur erfassung von stress induzierten proteinen
YU44292A (sh) Superaktivni analozi faktora oslobadjanja hormona rasta
Iwabuchi et al. Sialogogic effects on rat submandibular gland of analogs of the C-terminal hexapeptide of substance P

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties